Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer

Persistent Link:
http://hdl.handle.net/10150/610153
Title:
Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer
Author:
Facista, Alexander; Nguyen, Huy; Lewis, Cristy; Prasad, Anil; Ramsey, Lois; Zaitlin, Beryl; Nfonsam, Valentine; Krouse, Robert; Bernstein, Harris; Payne, Claire; Stern, Stephen; Oatman, Nicole; Banerjee, Bhaskar; Bernstein, Carol
Affiliation:
Department of Cellular and Molecular Medicine, College of Medicine, University of Arizona, Tucson, AZ 85724, USA; Department of Pathology, University of Arizona, Tucson, AZ 85724, USA; Pathology Department, Saint Marys Hospital, 1601 West Saint Marys Road, Tucson, AZ 85745, USA; Matrix Solutions Inc., 200, 150-13 Ave. S.W., Calgary, Alberta T2R 0V2, USA; Department of Surgery, University of Arizona, Tucson, AZ 85724, USA; Arizona Cancer Center, Tucson, Arizona 85724, USA; Southern Arizona Veterans Affairs Heath Care System, Mail Stop 0-151, 3601 S. 6th Ave., Tucson, Arizona 85723, USA; Biomedical Diagnostics and Research, 625 S. Plumer Ave, Tucson, AZ 85719, USA; Department of Medicine, University of Arizona, Tucson, AZ 85724, USA
Issue Date:
2012
Publisher:
BioMed Central
Citation:
Facista et al. Genome Integrity 2012, 3:3 http://www.genomeintegrity.com/content/3/1/3
Journal:
Genome Integrity
Rights:
© 2012 Facista et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0)
Collection Information:
This item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.
Abstract:
BACKGROUND:Cancers often arise within an area of cells (e.g. an epithelial patch) that is predisposed to the development of cancer, i.e. a "field of cancerization" or "field defect." Sporadic colon cancer is characterized by an elevated mutation rate and genomic instability. If a field defect were deficient in DNA repair, DNA damages would tend to escape repair and give rise to carcinogenic mutations.PURPOSE:To determine whether reduced expression of DNA repair proteins Pms2, Ercc1 and Xpf (pairing partner of Ercc1) are early steps in progression to colon cancer.RESULTS:Tissue biopsies were taken during colonoscopies of 77 patients at 4 different risk levels for colon cancer, including 19 patients who had never had colonic neoplasia (who served as controls). In addition, 158 tissue samples were taken from tissues near or within colon cancers removed by resection and 16 tissue samples were taken near tubulovillous adenomas (TVAs) removed by resection. 568 triplicate tissue sections (a total of 1,704 tissue sections) from these tissue samples were evaluated by immunohistochemistry for 4 DNA repair proteins. Substantially reduced protein expression of Pms2, Ercc1 and Xpf occurred in field defects of up to 10 cm longitudinally distant from colon cancers or TVAs and within colon cancers. Expression of another DNA repair protein, Ku86, was infrequently reduced in these areas. When Pms2, Ercc1 or Xpf were reduced in protein expression, then either one or both of the other two proteins most often had reduced protein expression as well. The mean inner colon circumferences, from 32 resections, of the ascending, transverse and descending/sigmoid areas were measured as 6.6 cm, 5.8 cm and 6.3 cm, respectively. When combined with other measurements in the literature, this indicates the approximate mean number of colonic crypts in humans is 10 million.CONCLUSIONS:The substantial deficiencies in protein expression of DNA repair proteins Pms2, Ercc1 and Xpf in about 1 million crypts near cancers and TVAs suggests that the tumors arose in field defects that were deficient in DNA repair and that deficiencies in Pms2, Ercc1 and Xpf are early steps, often occurring together, in progression to colon cancer.
EISSN:
2041-9414
DOI:
10.1186/2041-9414-3-3
Keywords:
"Colon cancer"; "DNA repair"; Pms2; Ercc1; Xpf; Ku86; "Genomic instability"; Cancerization; "Field defect"; Mutation
Version:
Final published version
Additional Links:
http://www.genomeintegrity.com/content/3/1/3

Full metadata record

DC FieldValue Language
dc.contributor.authorFacista, Alexanderen
dc.contributor.authorNguyen, Huyen
dc.contributor.authorLewis, Cristyen
dc.contributor.authorPrasad, Anilen
dc.contributor.authorRamsey, Loisen
dc.contributor.authorZaitlin, Berylen
dc.contributor.authorNfonsam, Valentineen
dc.contributor.authorKrouse, Roberten
dc.contributor.authorBernstein, Harrisen
dc.contributor.authorPayne, Claireen
dc.contributor.authorStern, Stephenen
dc.contributor.authorOatman, Nicoleen
dc.contributor.authorBanerjee, Bhaskaren
dc.contributor.authorBernstein, Carolen
dc.date.accessioned2016-05-20T08:59:47Z-
dc.date.available2016-05-20T08:59:47Z-
dc.date.issued2012en
dc.identifier.citationFacista et al. Genome Integrity 2012, 3:3 http://www.genomeintegrity.com/content/3/1/3en
dc.identifier.doi10.1186/2041-9414-3-3en
dc.identifier.urihttp://hdl.handle.net/10150/610153-
dc.description.abstractBACKGROUND:Cancers often arise within an area of cells (e.g. an epithelial patch) that is predisposed to the development of cancer, i.e. a "field of cancerization" or "field defect." Sporadic colon cancer is characterized by an elevated mutation rate and genomic instability. If a field defect were deficient in DNA repair, DNA damages would tend to escape repair and give rise to carcinogenic mutations.PURPOSE:To determine whether reduced expression of DNA repair proteins Pms2, Ercc1 and Xpf (pairing partner of Ercc1) are early steps in progression to colon cancer.RESULTS:Tissue biopsies were taken during colonoscopies of 77 patients at 4 different risk levels for colon cancer, including 19 patients who had never had colonic neoplasia (who served as controls). In addition, 158 tissue samples were taken from tissues near or within colon cancers removed by resection and 16 tissue samples were taken near tubulovillous adenomas (TVAs) removed by resection. 568 triplicate tissue sections (a total of 1,704 tissue sections) from these tissue samples were evaluated by immunohistochemistry for 4 DNA repair proteins. Substantially reduced protein expression of Pms2, Ercc1 and Xpf occurred in field defects of up to 10 cm longitudinally distant from colon cancers or TVAs and within colon cancers. Expression of another DNA repair protein, Ku86, was infrequently reduced in these areas. When Pms2, Ercc1 or Xpf were reduced in protein expression, then either one or both of the other two proteins most often had reduced protein expression as well. The mean inner colon circumferences, from 32 resections, of the ascending, transverse and descending/sigmoid areas were measured as 6.6 cm, 5.8 cm and 6.3 cm, respectively. When combined with other measurements in the literature, this indicates the approximate mean number of colonic crypts in humans is 10 million.CONCLUSIONS:The substantial deficiencies in protein expression of DNA repair proteins Pms2, Ercc1 and Xpf in about 1 million crypts near cancers and TVAs suggests that the tumors arose in field defects that were deficient in DNA repair and that deficiencies in Pms2, Ercc1 and Xpf are early steps, often occurring together, in progression to colon cancer.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttp://www.genomeintegrity.com/content/3/1/3en
dc.rights© 2012 Facista et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0)en
dc.subject"Colon cancer"en
dc.subject"DNA repair"en
dc.subjectPms2en
dc.subjectErcc1en
dc.subjectXpfen
dc.subjectKu86en
dc.subject"Genomic instability"en
dc.subjectCancerizationen
dc.subject"Field defect"en
dc.subjectMutationen
dc.titleDeficient expression of DNA repair enzymes in early progression to sporadic colon canceren
dc.typeArticleen
dc.identifier.eissn2041-9414en
dc.contributor.departmentDepartment of Cellular and Molecular Medicine, College of Medicine, University of Arizona, Tucson, AZ 85724, USAen
dc.contributor.departmentDepartment of Pathology, University of Arizona, Tucson, AZ 85724, USAen
dc.contributor.departmentPathology Department, Saint Marys Hospital, 1601 West Saint Marys Road, Tucson, AZ 85745, USAen
dc.contributor.departmentMatrix Solutions Inc., 200, 150-13 Ave. S.W., Calgary, Alberta T2R 0V2, USAen
dc.contributor.departmentDepartment of Surgery, University of Arizona, Tucson, AZ 85724, USAen
dc.contributor.departmentArizona Cancer Center, Tucson, Arizona 85724, USAen
dc.contributor.departmentSouthern Arizona Veterans Affairs Heath Care System, Mail Stop 0-151, 3601 S. 6th Ave., Tucson, Arizona 85723, USAen
dc.contributor.departmentBiomedical Diagnostics and Research, 625 S. Plumer Ave, Tucson, AZ 85719, USAen
dc.contributor.departmentDepartment of Medicine, University of Arizona, Tucson, AZ 85724, USAen
dc.identifier.journalGenome Integrityen
dc.description.collectioninformationThis item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.en
dc.eprint.versionFinal published versionen
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.